echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Notice of the 4th Beijing International Forum on Vaccine and Antibody Drug Innovation in 2022

    Notice of the 4th Beijing International Forum on Vaccine and Antibody Drug Innovation in 2022

    • Last Update: 2022-08-30
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Conference Background: Guiding Unit:
    Organizer: Organizer:
    [Time]
    [Location]
    [Form]
    [Meeting Scale] The
    scope of participation of the participants has been determined The schedule of the speaker meeting
    September 22 morning The main venue
    09:15-09:30  The opening speech of the leaders of the park
    09:30-10:00  Opportunities and challenges for the development of biopharmaceuticals in China
    10:00-10:30  The latest progress in the development of biological drugs
    10:30-11:00  coffee break, visit the exhibition
    11:00-11:30  Relevant regulatory requirements for biotech drug quality research
    11:30-12:00  Current Opportunities and Challenges of Biopharmaceutical CMC
    12:00-13:30  lunch break
    September 22 pm Topic 1 Vaccine development and evaluation
    13:30-14:00  Research and development of high-efficiency new crown antibody vaccine
    14:00-14:30  Key Problems and Countermeasures of Efficient Industrialized Production of Virus Vaccines
    14:30-15:00  Vaccine process validation and regulatory points
    15:00-15:30  coffee break, visit the exhibition
    15:30-16:00  Application and prospect of artificial intelligence in mRNA vaccine design
    16:00-16:30  Vaccine upstream and downstream production technology and quality control
    16:30-17:00  Overall design and development of mRNA vaccines
    16:30-17:00   Key points of innovative development of broad-spectrum coronavirus vaccine
    September 23rd morning Topic 2 Biopharmaceutical R&D Technology
    09:00-09:30  Research progress of antiviral therapeutic antibodies
    09:30-10:00  Development of Novel Antibody Conjugates
    10:00-10:20  coffee break, visit the exhibition
    10:20-10:50  Antibody Mass Production-Analysis of Cell Culture Process
    10:50-11:20  The importance of QBD from antibody design to industrial production
    11:20-11:50  Key points and case analysis of pharmaceutical research and development of monoclonal antibodies
    12:00-13:30  Conference lunch
    September 23rd afternoon Topic 3 Biopharmaceutical R&D Technology Branch venue
    13:30-14:00  Research progress of antibody drug quality control
    14:00-14:30  Application of Antibody Drugs in the Treatment of Tumors and Infectious Diseases
    14:30-15:00  coffee break, visit the exhibition
    15:00-15:30  Process optimization strategies in the process of technology transfer
    15:30-16:00  Bispecific antibody drug development technology
    16:00-16:30  the end of the conference
    Organizing Committee Office fanyu@swjslt.
    com
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.